V
Market Data
$0.63+$0.08 (+14.69%)
VTGN · Last trade
Prev Close
$0.55
Range (27d)
$0.51 – $0.63
Recent Filings
- 8-K139.3 KBVistagen Therapeutics, Inc.Mar 11, 7:02 AM ET·0001628280-26-016652
- 8-K134.5 KBVistagen Therapeutics, Inc.Feb 20, 9:12 AM ET·0001628280-26-010035
- 10-Q5.1 MBVistagen Therapeutics, Inc.Feb 12, 4:38 PM ET·0001628280-26-007718
- 8-K256.2 KBVistagen Therapeutics, Inc.Feb 12, 4:35 PM ET·0001628280-26-007715
- 8-K138.0 KBVistagen Therapeutics, Inc.Feb 6, 4:12 PM ET·0001628280-26-006078
- 8-K7.8 MBVistagen Therapeutics, Inc.Jan 9, 5:26 PM ET·0001628280-26-001690
- 8-K135.1 KBVistagen Therapeutics, Inc.Dec 22, 5:29 PM ET·0001628280-25-058594
- 8-K299.7 KBVistagen Therapeutics, Inc.Dec 3, 4:47 PM ET·0001628280-25-055083
- 10-Q5.1 MBVistagen Therapeutics, Inc.Nov 13, 4:35 PM ET·0001628280-25-052079
- 8-K253.9 KBVistagen Therapeutics, Inc.Nov 13, 4:34 PM ET·0001628280-25-052077
Insiders
10- Adler Reid G.Chief Legal Officer
- Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
- Bonfiglio Gregory A.Director
- Cato Allen Easley10% Owner
- Commodore Capital LP10% Owner
- Cote Elissa S.Chief Corp Development Officer
- Cunningham Ann MichelleDirector
- Curley JoanneDirector
- DOTSON JERROLD DUANEACTING CFO
- Edick Paul RDirector
Tickers
Addresses
business
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Excaliber Enterprises, Ltd.2011-06-08